Xencor XNCR
NASDAQ XNCR
$26.61 -0.01 (-0.04%)
As of: Sep 4, 2026 · 3:59 PM EDT

Xencor (XNCR) Non Operating Income (2013 - 2026)

Xencor (XNCR) posted quarterly Non Operating Income of -$50.8 million for Q1 2026, down 899.09% year-over-year from $6.4 million in Q1 2025, and down 202.86% quarter-over-quarter from $49.4 million in Q4 2025.

Analysis

Xencor (XNCR) Non Operating Income (2013 - 2026) Analysis & Trends

Xencor (XNCR) has reported Non Operating Income for 14 consecutive years, with -$50.8 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Non Operating Income fell 899.09% year-over-year to -$50.8 million; the TTM figure through Mar 2026 stood at $42.2 million (up 200.08% YoY), while the FY2025 annual figure was $87.9 million, up 255.48% from the prior year.
  • Non Operating Income slipped to -$50.8 million in Q1 2026 per XNCR's latest filing, from $49.4 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $49.4 million in Q4 2025 and bottomed at -$50.8 million in Q1 2026.
  • Historically, Non Operating Income has averaged $1.3 million across 5 years, with a median of -$19000.0 in 2023.
  • Annual changes were most pronounced in 2022 — Non Operating Income jumped 502.07% — and 2024, when it tumbled 102284.21%.
  • Xencor's Non Operating Income stood at $30.1 million in 2022, then plunged by 46.63% to $16.1 million in 2023, then sank by 295.26% to -$31.4 million in 2024, then jumped by 257.18% to $49.4 million in 2025, then tumbled by 202.86% to -$50.8 million in 2026.
  • Business Quant data shows XNCR's Non Operating Income at -$50.8 million in Q1 2026, $49.4 million in Q4 2025, and $41.5 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 234.30 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -139.24 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -53.64 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -51.63 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Xencor 2.02 Bn 1.65 Bn - 15.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.15 Mn
Mar 31, 2026 -50.77 Mn
Dec 31, 2025 49.36 Mn
Sep 30, 2025 41.49 Mn
Jun 30, 2025 2.10 Mn
Mar 31, 2025 -5.08 Mn
Dec 31, 2024 -31.41 Mn
Sep 30, 2024 7.76 Mn
Jun 30, 2024 -13.41 Mn
Mar 31, 2024 -19.45 Mn
Dec 31, 2023 16.08 Mn
Sep 30, 2023 -6.00 Mn
Jun 30, 2023 4.04 Mn
Mar 31, 2023 -19,000.00
Dec 31, 2022 30.14 Mn
Sep 30, 2022 6.68 Mn
Jun 30, 2022 -5.98 Mn
Mar 31, 2022 -2.87 Mn
Dec 31, 2021 -18.59 Mn
Sep 30, 2021 1.11 Mn